Peijia Medical completes first U.S. patient implant in GeminiOne TEER early feasibility study

Bulletin Express

Apr 09

Peijia Medical Limited (Peijia Medical) has announced the successful completion of the first patient implant in the U.S. Food and Drug Administration Early Feasibility Study for its GeminiOne® Transcatheter Edge-to-Edge Repair (TEER) system. The procedure, performed by Professor Saibal Kar at Los Robles Regional Medical Center, marks the company’s initial clinical milestone in the United States for this structural-heart intervention technology.

The company highlighted that, while the milestone advances GeminiOne’s clinical development, there is no assurance the device will ultimately achieve full regulatory approval or commercialization. Investors are urged to exercise caution when dealing in Peijia Medical’s shares.

The announcement was released on 9 April 2026 and approved by the Board, chaired by Executive Director Dr. Yi Zhang.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1108148998"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108148998\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108148998?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-09 18:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108148998","market":"us","top_or_hot":-1,"title":"Peijia Medical completes first U.S. patient implant in GeminiOne TEER early feasibility study","media":"Bulletin Express","content":"<p>Peijia Medical Limited (Peijia Medical) has announced the successful completion of the first patient implant in the U.S. Food and Drug Administration Early Feasibility Study for its GeminiOne® Transcatheter Edge-to-Edge Repair (TEER) system. The procedure, performed by Professor Saibal Kar at Los Robles Regional Medical Center, marks the company’s initial clinical milestone in the United States for this structural-heart intervention technology.</p>\n<p>The company highlighted that, while the milestone advances GeminiOne’s clinical development, there is no assurance the device will ultimately achieve full regulatory approval or commercialization. Investors are urged to exercise caution when dealing in Peijia Medical’s shares.</p>\n<p>The announcement was released on 9 April 2026 and approved by the Board, chaired by Executive Director Dr. Yi Zhang.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peijia Medical completes first U.S. patient implant in GeminiOne TEER early feasibility study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeijia Medical completes first U.S. patient implant in GeminiOne TEER early feasibility study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-09 18:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Peijia Medical Limited (Peijia Medical) has announced the successful completion of the first patient implant in the U.S. Food and Drug Administration Early Feasibility Study for its GeminiOne® Transcatheter Edge-to-Edge Repair (TEER) system. The procedure, performed by Professor Saibal Kar at Los Robles Regional Medical Center, marks the company’s initial clinical milestone in the United States for this structural-heart intervention technology.</p>\n<p>The company highlighted that, while the milestone advances GeminiOne’s clinical development, there is no assurance the device will ultimately achieve full regulatory approval or commercialization. Investors are urged to exercise caution when dealing in Peijia Medical’s shares.</p>\n<p>The announcement was released on 9 April 2026 and approved by the Board, chaired by Executive Director Dr. Yi Zhang.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09996","symbol_name":"沛嘉医疗-B","start_time":0,"source_url":"","article_id":"1108148998","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108148998","pubTimestamp":1775731623,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Peijia Medical Limited (Peijia Medical) has announced the successful completion of the first patient implant in the U.S. Food and Drug Administration Early Feasibility Study for its GeminiOne®...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09996":"沛嘉医疗-B"},"translate_title":"沛嘉医疗在GeminiOne TEER早期可行性研究中完成首例美国患者植入","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09996":1},"content_text":"Peijia Medical Limited (Peijia Medical) has announced the successful completion of the first patient implant in the U.S. Food and Drug Administration Early Feasibility Study for its GeminiOne® Transcatheter Edge-to-Edge Repair (TEER) system. The procedure, performed by Professor Saibal Kar at Los Robles Regional Medical Center, marks the company’s initial clinical milestone in the United States for this structural-heart intervention technology.\nThe company highlighted that, while the milestone advances GeminiOne’s clinical development, there is no assurance the device will ultimately achieve full regulatory approval or commercialization. Investors are urged to exercise caution when dealing in Peijia Medical’s shares.\nThe announcement was released on 9 April 2026 and approved by the Board, chaired by Executive Director Dr. Yi Zhang.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}